drugset / Trial / NCT07593885

A Study to Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Eye Drops in the Management of Moderate to Severe Dry Eye Disease

NCT07593885 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

A Double-Masked, Randomized, Parallel Group, Non-Inferiority Study to Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Eye Drops in the Management of Moderate to Severe Dry Eye Disease

Timeline

Start
2026-04-30
Primary completion
2026-11
Completion
2026-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Artelac® Complete MDO® Eye Drops Unknown — Other
Comparator VISMED® MULTI Eye Drops Unknown — Other

Indications